Search Results - Orit Cohen-Barak
- Showing 1 - 1 results of 1
-
1
Scaling Approaches for Pediatric Dose Selection: The Fremanezumab (AJOVY<sup>®</sup>) Journey to Select a Phase 3 Dose Using Pharmacokinetic Data from a Phase 1 Study by Aksana Jones, Orit Cohen-Barak, Andrijana Radivojevic, Jill Fiedler-Kelly
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book